NCT01453803 Study to Assess the Safety and Effects of Autologous Adipose-Derived SVF Cells in Patients With Parkinson's Disease Status WITHDRAWN Phase NA
NCT01446939 Imaging in the Diagnosis of Parkinson's Disease and Essential Tremor Status UNKNOWN Phase N/A
NCT01446614 Mesenchymal Stem Cells Transplantation to Patients With Parkinson's Disease Status UNKNOWN Phase PHASE1/PHASE2
NCT01446549 Motor Performance in Parkinson's Disease After High Intensive Exercise or Deep Brain Stimulation Status COMPLETED Phase NA
NCT01429909 Optimization of fMRI for the Study of Basal Ganglia Activation in Parkinson's Disease Status COMPLETED Phase NA
NCT01429220 Automated Parkinson's Disease (PD) Motor Symptom Assessment for Deep Brain Stimulation (DBS) Programming Status COMPLETED Phase N/A
NCT01429207 Capturing Parkinson's Disease Medication Side Effects During Daily Activities Status COMPLETED Phase N/A
NCT01427530 Local Field Potentials Recorded From Deep Brain Stimulating (DBS) Electrodes Status COMPLETED Phase N/A
NCT01427517 Intravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's Disease Status COMPLETED Phase PHASE1
NCT01427062 Effects of an Innovative Balance Training Programme in Enhancing Postural Control and Reducing Falls in Patients With Parkinson's Disease Status UNKNOWN Phase NA
NCT01423565 Comparison of Constant Current to Constant Voltage Stimulation in Subthalamic Deep Brain Stimulation for Parkinson's Disease Status COMPLETED Phase NA
NCT01421719 Safety and Efficacy of botulinumA Toxin (BotoxA) for Treatment of Neurogenic Bladder of Parkinson's Disease Status COMPLETED Phase PHASE4
NCT01411137 Carbidopa-Levodopa (CD-LD) ER Alone or in Combination With CD-LD IR to IPX066 Followed by IPX066 Extension Safety Study Status COMPLETED Phase PHASE3
NCT01399905 High and Low Dose Carbidopa Treatment of Parkinson's Disease Status COMPLETED Phase PHASE2
NCT01397422 Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study) Status COMPLETED Phase PHASE2/PHASE3
NCT01382342 The Effect of Rasagiline on Cognition in Parkinson's Disease Status COMPLETED Phase PHASE4